Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study

Author:

Rigolin Gian Matteo1ORCID,Del Giudice Ilaria2,Bardi Antonella1,Melandri Aurora1,García-Jacobo Rocio Edith1ORCID,Cura Francesca1,Raponi Sara2,Ilari Caterina2,Cafforio Luciana2,Piciocchi Alfonso3ORCID,Arena Valentina3ORCID,Reda Gianluigi4,Albano Francesco5ORCID,Molica Stefano6ORCID,Sportoletti Paolo7,Trentin Livio8ORCID,Marchetti Monia9,Nanni Mauro2,Peragine Nadia2ORCID,Mariglia Paola2,Vignetti Marco3ORCID,Guarini Anna10,Mauro Francesca Romana2,Foà Robin2,Cuneo Antonio1

Affiliation:

1. Hematology Section, St Anna University Hospital, Ferrara, Italy;

2. Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy;

3. Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA) Data Center, GIMEMA Foundation, Rome, Italy;

4. Hematology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy;

5. Hematology Section, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy;

6. Hematology, Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy;

7. Institute of Hematology and Center for Hemato-Oncological Research, Ospedale S Maria della Misericordia, University of Perugia, Perugia, Italy;

8. Hematology Unit, University of Padua, Padua, Italy;

9. Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; and

10. Department of Molecular Medicine, Sapienza University, Rome, Italy

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3